Cardos Rosca Medical S.R.L.
- Address
- Strada Frunzisului Nr. 108, 400664 Cluj Napoca, Romania
Cardos Rosca Medical S.R.L. - Respiratory Research Center
Cardos Rosca Medical S.R.L. is a specialized clinical research facility dedicated to advancing treatment options for patients with chronic respiratory diseases. The center demonstrates particular expertise in conducting complex respiratory trials, with a focused commitment to evaluating novel therapeutic interventions for Chronic Obstructive Pulmonary Disease (COPD) and related conditions including chronic bronchitis.
- Advanced COPD exacerbation reduction studies with triple therapy combinations
- Novel inhaled medication delivery systems and dry powder inhaler (DPI) technologies
- Long-term efficacy and safety evaluations in chronic bronchitis populations
The research center has established significant experience in evaluating add-on maintenance therapies to standard triple therapy regimens (ICS, LABA, LAMA), conducting year-long clinical trials to assess exacerbation rates and patient outcomes. Their expertise encompasses both fixed and free combination therapeutic approaches, positioning them as a key contributor to understanding optimal treatment strategies for patients with severe COPD requiring intensive medical management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chiesi Farmaceutici S.p.A.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cardos Rosca Medical S.R.L.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Tanimilast (CHF6001) as an Add-On to Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis | Chiesi Farmaceutici S.p.A. | Phase III | Not Recruiting | Jun 2021 | Jun 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tanimilast | 2 | Unknown | 2021-06-16 | 2021-06-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.